Home/Filings/4/0001144204-18-047575
4//SEC Filing

Jantzen Beth 4

Accession 0001144204-18-047575

CIK 0000744452other

Filed

Aug 30, 8:00 PM ET

Accepted

Aug 31, 4:07 PM ET

Size

5.4 KB

Accession

0001144204-18-047575

Insider Transaction Report

Form 4
Period: 2018-08-29
Jantzen Beth
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-08-29+100,000100,000 total
    Exercise: $1.19From: 2018-08-29Exp: 2028-08-28Common Stock (100,000 underlying)

Issuer

APPLIED DNA SCIENCES INC

CIK 0000744452

Entity typeother

Related Parties

1
  • filerCIK 0001633940

Filing Metadata

Form type
4
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 4:07 PM ET
Size
5.4 KB